| "A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study to DemonstrateEfficacy and Safety of A4250 in Children with Progressive Familial IntrahepaticCholestasis Types 1 and 2 (PEDFIC 1)" |
Ongoing |
A4250 |
3 |
A4250-005 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| An International, Double-blind, Randomised, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)DELIVER - Dapagliflozin Evaluation to Improve the LIVEs of Patients with PReserved Ejection Fraction Heart Failure |
Ongoing |
Dapagliflozin |
3 |
D169CC00001 |
King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz University Hospital (Jeddah), Saud Al-Babtain Cardiac Center (Dammam), King Abdulaziz Medical City NG (Riyadh), King Fahad Medical City (Riyadh) |
| Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS) |
Ongoing |
Dantrolene |
2 |
EGL-4104-C-1801 |
King Faisal General Hospital (Makkah), Mina Al-Jisr Hospital, Mina Al-Wadi Hospital, Mina Al-Shari' Al-Jadid Hospital |
| A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (NAVIGATOR) |
Ongoing |
Tezepelumab |
3 |
D5180C00007 |
King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy. |
Terminated |
Risdiplam |
2 |
BP39056 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial |
Ongoing |
Cinnamon |
3 |
100-18 |
King Abdulaziz University Hospital (Jeddah) |
| Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study |
Ongoing |
Apixaban |
4 |
2018-08 |
Saud Al-Babtain Cardiac Center (Dammam)N/A |
| "AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting." |
Ongoing |
Aflibercept |
4 |
191 57 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh) |
| An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD |
Ongoing |
Remsima |
4 |
RMS-KSA-20 |
King Abdulaziz University Hospital (Jeddah) |
| Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. |
Ongoing |
Enoxa / Enoxaparin |
BE |
21-2017 v.02 |
Saudi Ajal |
